Nello Mainolfi, CEO: Kymera Therapeutics KYMR Planned sale · Filed 04/29

Trade details

Type: Planned sale notice
Stock: Kymera Therapeutics KYMR
Person: Nello MainolfiCEO
Planned sale date: 26/04/29
Filed: 26/04/29

More to sell after $2.7M in 3 months

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 03/30~05/29

Nello Mainolfi's recent trades

Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$949.7K
8,230 sh
$949.7K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$869.8K
7,601 sh
$869.8K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$619K
5,506 sh
$619K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$552.2K
4,876 sh
$552.2K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$392.8K
3,525 sh
$392.8K
Filed 10/01
Traded 10/01

Nello Mainolfi, CEO — plans to sell 30,000 sh of Kymera Therapeutics KYMR · $2.5M · around 04/29 · 10b5-1 plan | Whalegun